Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists

Stroke

Volumn 28, Issue 2, 1997, Pages 364-369

  Kataoka, Satoshi ^b   Alam, Rita ^c   Dash, Pramod K ^a   Yatsu, Frank M ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NONE

Author keywords

atherosclerosis; calcium channel blockers; muscle, smooth

Indexed keywords

CALCIUM ANTAGONIST; CLENTIAZEM; DILTIAZEM; INOSITOL PHOSPHATE; NIFEDIPINE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR AP 1; VERAPAMIL;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0031037877     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.2.364     Document Type: Article

References (36)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell. 1986;46:155-169.
3. Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science. 1989;243:1564-1570.
4. Barrett TB, Benditt EP. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci U S A. 1987;84:1099-1103.
5. Barrett TB, Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A. 1988;85:2810-2814.
6. Majesky MW, Benditt EP, Schwartz SM. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/ Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1988;85:1524-1528.
7. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
8. Nabel EG, Yang Z, Liptay S, San H, Gordon D. Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
9. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem. 1990;265:10238-10243.
10. Kondo T, Konishi F, Inui H, Inagami T. Differing signal transductions elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells. J Biol Chem. 1993;268:4458-4464.
11. Kruijer W, Cooper JA, Hunter T, Verma IM. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature. 1984;312:711-716.
12. Hall DJ, Stiles CD. Platelet-derived growth factor-inducible genes respond differentially to at least two distinct intracellular second messengers. J Biol Chem. 1987;262:15302-15308.
13. Curran T. Franza BR. Fos and Jun: the AP-1 connection. Cell. 1988;55:395-397.
14. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta. 1991;1072:129-157.
15. Jackson LJ, Bush RC, Bowyer DE. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis. 1988;8:115-122.
16. Nilsson J, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis. 1985;58:109-122.
17. Jackson CL, Bush RC, Bowyer D. Mechanism of antiatherogenic action of calcium antagonists. Atherosclerosis. 1989;80:17-26.
18. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1989;86:2388-2392.
19. 2+-channel blockers involves protein kinase C isoforms. Proc Natl Acad Sci U S A. 1993;90:4097-4101.
20. Erusalimsky JD, Friedberg I, Rozengurt E. Bombesin, diacylglycerols, and phorbol esters rapidly stimulate the phosphorylation of an Mr=80,000 protein kinase C substrate in permeabilized 3T3 cells. J Biol Chem. 1988;263:19188-19194.
21. Dignam JD Lebowitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
22. Dash PK, Moore AN. A peptide containing the leucine zipper domain specifically inhibits CREB binding and transcription. Cell Mol Biol. 1993;39:35-43.
23. 2+ channels in rat aorta smooth muscle cells in primary culture. Circ Res. 1990;67:469-480.
24. 2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol. 1993;265(Cell Physiol 34):C1239-C1246.
25. 2+ transport by platelet-derived growth factor-BB in rat vascular smooth muscle cells. Circ Res. 1993;72:847-856.
26. Hart CE, Forstrom JW, Kelly JD, Seifert RA, Smith RA, Ross R, Murray MJ, Bowen-Pope DF. Two classes of PDGF receptor recognize different isoforms of PDGF. Science. 1988;240:1529-1531.
27. Inui H, Kitami Y, Tani M, Kondo T, Inagami T. Differences in signal transduction between platelet-derived growth factor (PDGF) α and β receptors in vascular smooth muscle cells. J Biol Chem. 1994;269:30546-30552.
28. Marks AR. Calcium channels expressed in vascular smooth muscle. Circulation. 1992;86(suppl III):III-61-III-67.
29. Mori T, Takai Y, Minakuchi R, Yu B, Nishizuka Y. Inhibitory action of chlorpromazine, dibucaine, and other phosphohpid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J Biol Chem. 1980;255:8378-8380.
30. 2+-dependent processes. Proc Natl Acad Sci U S A. 1986;83:3733-3737.
31. Takahashi M, Seagar MJ, Jones JF, Reber BFX, Catterall WA. Sub-unit structure of dihydropyridine-sensitive calcium channels from skeletal muscle. Proc Natl Acad Sci U S A. 1987;84:5478-5482.
32. Cadena DL, Gill GN. Receptor tyrosine kinase. FASEB J. 1992;6:2332-2337.
33. Hughes AD, Patel M, Wijetunge S, Clunn G, Schachter M. Comparison of effects of platelet-derived growth factor isoforms on signaling and DNA synthesis of human cultured saphenous vein cells. J Cardiovasc Pharmacol. 1995;25:481-485.
34. Lee W, Haslinger A, Karin M, Tijian R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV 40. Nature. 1987;325:368-372.
35. Dash PK, Moore AN, Dixon CE. Spatial memory deficit, increased phosphorylation of the transcription factor CREB. and induction of the AP-1 complex following experimental brain injury. J Neurosci. 1995;15:2030-2039.
36. Alam R, Kataoka S, Alam S, Yatsu FM. Inhibition of vascular smooth muscle cell proliferation by the calcium antagonist clentiazem: role of protein kinase C. Atherosclerosis. 1996;126:207-219.